We not only studied the role of ELK3 as a carcinogenic gene in the occurrence and development of gliomas, but also identified four small-molecule compounds with inhibitory effects on ELK3: sanguinarine, omeprazole, rimexolone, and phthalylsulfathiazole. This evidence concerns the gene ELK3 and central nervous system cancer.